Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis. (2017)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/aac.01054-17
PubMed Identifier: 28827417
Publication URI: http://europepmc.org/abstract/MED/28827417
Type: Journal Article/Review
Volume: 61
Parent Publication: Antimicrobial agents and chemotherapy
Issue: 11
ISSN: 0066-4804